Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H18N2O7 |
Molecular Weight | 302.2805 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@](O)(CO)[C@H](O)[C@@]12NC(=O)[C@@](O)(NC1=O)C(=C)CCO2
InChI
InChIKey=WOUDXEYYJPOSNE-VKZDFBPFSA-N
InChI=1S/C12H18N2O7/c1-6-3-4-21-12(7(16)10(2,19)5-15)9(18)13-11(6,20)8(17)14-12/h7,15-16,19-20H,1,3-5H2,2H3,(H,13,18)(H,14,17)/t7-,10-,11+,12-/m0/s1
Molecular Formula | C12H18N2O7 |
Molecular Weight | 302.2805 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16181146
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16181146
Bicyclomycin has been used to treat diarrhea in humans and bacterial diarrhea in calves and pigs and is marketed by Fujisawa (Osaka, Japan) under the trade name Bicozamycin. This drug is the selective inhibitor of rho, a member of the RecA-type ATPase class of enzymes that use nucleotide contacts to couple oligonucleotide translocation to ATP hydrolysis.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3965336
None of the 11 subjects given bicozamycin orally for 3 wk at a dosage of 500 mg four times a day developed diarrhea as compared with an incidence of 53% diarrhea (10 of 19 subjects) in the placebo group (p = 0.003).
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:48:28 GMT 2023
by
admin
on
Sat Dec 16 17:48:28 GMT 2023
|
Record UNII |
J03U9E2P82
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
180516
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
4356
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
100000085900
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103766
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
253-795-3
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
C024504
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
65807
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
SUB05822MIG
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
Bicyclomycin
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
38129-37-2
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
C90933
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
J03U9E2P82
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
DTXSID8042636
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
60584
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | |||
|
m2477
Created by
admin on Sat Dec 16 17:48:28 GMT 2023 , Edited by admin on Sat Dec 16 17:48:28 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |